- $49.27m
- $37.30m
- $25.18m
- 55
- 23
- 55
- 41
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 6.53 | ||
Price to Tang. Book | 6.53 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.96 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -107.45% | ||
Return on Equity | -158.63% | ||
Operating Margin | -48.3% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 3.5 | 5.45 | 8.59 | 16.03 | 25.18 | 32.64 | 47.74 | 60.15% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.
Directors
- Peter Cuneo CHM (77)
- Daniel Goldberger CEO (62)
- Brian Posner CFO (59)
- Joseph Errico DRC (52)
- Michael Atieh IND (67)
- Thomas Errico IND (69)
- John Gandolfo IND (61)
- Trevor Moody IND (56)
- Stephen Ondra IND (64)
- Thomas Patton IND (57)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 13th, 2005
- Public Since
- June 22nd, 2018
- No. of Shareholders
- 404
- No. of Employees
- 73
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 7,193,092

- Address
- 200 FORGE WAY, SUITE 205, ROCKAWAY, 07866
- Web
- https://www.electrocore.com/
- Phone
- +1 9732900097
- Auditors
- Marcum LLP
Upcoming Events for ECOR
Q1 2025 electroCore, Inc. Earnings Call
Q2 2025 electroCore, Inc. Earnings Release
electroCore, Inc. Annual Shareholders Meeting
Similar to ECOR
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
As of Today at 20:25 UTC, shares in electroCore,. are trading at $6.85. This share price information is delayed by 15 minutes.
Shares in electroCore,. last closed at $6.85 and the price had moved by +11.93% over the past 365 days. In terms of relative price strength the electroCore,. share price has outperformed the S&P500 Index by +0.93% over the past year.
The overall consensus recommendation for electroCore,. is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreelectroCore,. does not currently pay a dividend.
electroCore,. does not currently pay a dividend.
electroCore,. does not currently pay a dividend.
To buy shares in electroCore,. you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $6.85, shares in electroCore,. had a market capitalisation of $49.27m.
Here are the trading details for electroCore,.:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ECOR
Based on an overall assessment of its quality, value and momentum electroCore,. is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in electroCore,. is $25.20. That is 267.88% above the last closing price of $6.85.
Analysts covering electroCore,. currently have a consensus Earnings Per Share (EPS) forecast of -$1.26 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like electroCore,.. Over the past six months, its share price has underperformed the S&P500 Index by -40.32%.
As of the last closing price of $6.85, shares in electroCore,. were trading -33.78% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The electroCore,. PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $6.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
electroCore,.'s management team is headed by:
- Peter Cuneo - CHM
- Daniel Goldberger - CEO
- Brian Posner - CFO
- Joseph Errico - DRC
- Michael Atieh - IND
- Thomas Errico - IND
- John Gandolfo - IND
- Trevor Moody - IND
- Stephen Ondra - IND
- Thomas Patton - IND